1. ScholarBank@NUS

Si-Shen Feng

rp04215

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Si-Shen Feng
Variants
Feng S.-S.
Feng, S.S.
Feng, S.S
Feng, S.
Si-Shen, F.
Feng, S.-s.
Feng, S.-S.
Shen, F.S.
 
Main Affiliation
 
Faculty
 
Email
chefss@nus.edu.sg
 

Publications

Results 61-80 of 110 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
61Aug-2010Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performanceLiu, Y.; Pan, J.; Feng, S.-S. 
62Jul-2006Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxelDong, Y. ; Feng, S.-S. 
63Apr-2007Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug deliveryLee, S.H.; Zhang, Z. ; Feng, S.-S. 
64Apr-2007Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug deliveryLee, S.H.; Zhang, Z. ; Feng, S.-S. 
65Jan-2006Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug releaseZhang, Z. ; Feng, S.-S. 
66Sep-2000Nanospheres of biodegradable polymers: A system for clinical administration of an anticancer drug paclitaxel (Taxol®)Feng, S.S. ; Huang, G.F.; Mu, L. 
6718-Apr-2005Novel powder formulations for controlled delivery of poorly soluble anticancer drug: Application and investigation of TPGS and PEG in spray-dried particulate systemMu, L. ; Teo, M.-M.; Ning, H.-Z.; Tan, C.-S.; Feng, S.-S. 
814-Oct-2011Novel synthesis of superparamagnetic magnetite nanoclusters for biomedical applicationsMaity, D.; Chandrasekharan, P.; Pradhan, P.; Chuang, K.-H.; Xue, J.-M. ; Feng, S.-S. ; Ding, J. 
9Nov-2003PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading RatioMu, L. ; Feng, S.-S. 
105-Sep-2007Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapyDong, Y. ; Feng, S.-S. 
11Oct-2005Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsDong, Y. ; Feng, S.-S. 
12Oct-2005Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsDong, Y. ; Feng, S.-S. 
13Jul-2009Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of DocetaxelFeng, S.-S. ; Mei, L. ; Anitha, P.; Gan, C.W.; Zhou, W.
14Oct-2009Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene deliveryYang, Y. ; Lo, S.-L.; Yang, J.; Yang, J.; Goh, S.S.L.; Wu, C.; Feng, S.-S. ; Wang, S. 
1521-Jan-2011Polyhedral oligomeric silsesquioxanes-containing conjugated polymer loaded PLGA nanoparticles with trastuzumab (herceptin) functionalization for HER2-positive cancer cell detectionLi, K.; Liu, Y.; Pu, K.-Y. ; Feng, S.-S. ; Zhan, R.; Liu, B. 
1631-May-2002Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®)Feng, S.-S. ; Mu, L. ; Chen, B.-H. ; Pack, D.
17Dec-2003Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxelRuan, G.; Feng, S.-S. 
18Feb-2012Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blendZhao, J.; Mi, Y.; Liu, Y.; Feng, S.-S. 
19Feb-2012Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blendZhao, J.; Mi, Y.; Liu, Y.; Feng, S.-S. 
20May-2003Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiationWang, J. ; Ng, C.W.; Win, K.Y. ; Shoemakers, P.; Lee, T.K.Y.; Feng, S.S. ; Wang, C.H.